• No results found

Prognosis in monoclonal proteinaemia Schaar, C.G.

N/A
N/A
Protected

Academic year: 2021

Share "Prognosis in monoclonal proteinaemia Schaar, C.G."

Copied!
3
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Prognosis in monoclonal proteinaemia

Schaar, C.G.

Citation

Schaar, C. G. (2006, November 9). Prognosis in monoclonal

proteinaemia. Retrieved from https://hdl.handle.net/1887/4983

Version:

Corrected Publisher’s Version

License:

Licence agreement concerning inclusion of

doctoral thesis in the Institutional Repository of

the University of Leiden

Downloaded from:

https://hdl.handle.net/1887/4983

(2)

List of publications

1. Spronk PE, Rommes JH, Schaar CG, Ince C. Thrombolysis in fulminant purpura: observations on changes in microcirculatory perfusion during successful treatment. Thromb Haemost 2006;95:576-578.

2. Bemelmans RH, van Toorn DW, van LL, Schaar CG. Long-term complete remission in IgD-myeloma. Eur J Haematol 2006;76:339-341.

3. Schaar CG, Vermeer HJ, Wijermans PW et al. Serum syndecan-1 in patients with newly diag-nosed monoclonal proteinemia. Haematologica 2005;90:1437-1438.

4. Schaar CG, Kluin-Nelemans HC, Te MC et al. Interferon-alpha as maintenance therapy in patients with multiple myeloma. Ann Oncol 2005;16:634-639.

5. Schaar CG, Snijder S, Oostindier MJ et al. Monoclonal proteinaemia and solid tumours. Eur J Cancer 2004;40:1539-1544.

6. Schaar CG, Kluin-Nelemans JC, le CS et al. Early response to therapy and survival in multiple myeloma. Br J Haematol 2004;125:162-166.

7. Schaar CG, van der Pijl JW, van HB et al. Successful outcome with a “quintuple approach” of posttransplant lymphoproliferative disorder. Transplantation 2001;71:47-52.

8. Schaar CG, Ronday KH, Boets EP, van der Lubbe PA, Breedveld FC. Catastrophic manifesta-tion of the antiphospholipid syndrome. J Rheumatol 1999;26:2261-2264.

9. Schaar CG, Kaiser U, Snijder S et al. Serum interleukin-6 has no discriminatory role in para-proteinaemia nor a prognostic role in multiple myeloma. Br J Haematol 1999;107:132-138. 10. Ong F, Hermans J, Noordijk EM, Schaar CG, Kluin-Nelemans JC. The classification of plasma

cell dyscrasias: alternatives to the Durie & Salmon diagnostic system. Leuk Lymphoma 1999;34:203-206.

11. Dawson L, Schaar CG, de Meijer PH, Meinders AE. Addisonian crisis provoked by levothyrox-ine substitution therapy. Ned Tijdschr Geneeskd 1998;142:1826-1829.

12. Schaar CG, Ong F, Snijder S et al. The risk of a multiple myeloma in patients with parapro-teinemia: a myeloma risk score developed in the region of the Comprehensive Cancer Center West. Ned Tijdschr Geneeskd 1998;142:1591-1595.

13. Schaar CG, Brouwer OF, Wondergem JH. Watershed infarction after near drowning in a two year old child. Clin Neurol Neurosurg 1991;93:159-161.

14. Res PC, Schaar CG, Breedveld FC et al. Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet 1988;2:478-480.

139

(3)

140

Referenties

GERELATEERDE DOCUMENTEN

In a previous study, using our database that also included a large number of patients with multiple myeloma, we devised a Myeloma Risk Score using the M-protein serum level and

Therefore, the relation between survival and the rate of monoclonal protein (M-protein) decrement during the first cycles of therapy was prospectively assessed in 262 patients

Background: The effect of interferon- α 2b (IFN-α) on progression free and overall survival as well as quality of life was studied in mainly elderly patients with multiple myeloma

Not surprisingly, survival was also influenced by the M-protein related internal diagnosis especially MGUS associated with a solid tumour (median 0.4 (95% CI 0.2-0.5) years) compared

Serum IL-6 spiegels werden bepaald in 212 duidelijk omschreven patiënten met M- proteïnemie: multipel myeloom (60), andere hematologische ziekten (46), solide tumoren

The population-based Paraprotein database was established at the Comprehensive Cancer Centre West (CCCW, Integraal Kankercentrum West) in cooperation with the physicians

Hierna was hij negen maanden werkzaam als arts-assistent niet in opleiding op de afdeling Interne Geneeskunde van het Bronovo Ziekenhuis te Den Haag, alwaar per 1 januari 1993

CCCW Comprehensive Cancer Centre West (Integraal Kanker Centrum West; IKW) CRP C-reactive protein. HOVON Hematologie Oncologie Volwassenen Nederland